CMPX Reports $195M Cash, $17.1% ORR, +94% PFS, FDA BLA Planned, ASCO Data, $20B Deal
Compass Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $2.22
-6.2% in 3d after detection
Post-detection moves
1h
—
1d
-4.1%
3d
-6.2%
7d
+1.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS